VERA Q2 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$563,000

Operating Income

-$80M

Net Income

-$77M

EPS (Diluted)

$-1.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$579M

Total Liabilities

$110M

Stockholders' Equity

$468M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$563,000	$0	—
Operating Income	-$80M	-$37M	-114.6%
Net Income	-$77M	-$34M	-127.0%